551.25
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$546.51
Offen:
$544.75
24-Stunden-Volumen:
2.05M
Relative Volume:
0.86
Marktkapitalisierung:
$197.61B
Einnahmen:
$9.61B
Nettoeinkommen (Verlust:
$2.77B
KGV:
72.96
EPS:
7.555
Netto-Cashflow:
$2.27B
1W Leistung:
+20.24%
1M Leistung:
+24.97%
6M Leistung:
+7.12%
1J Leistung:
+7.82%
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ISRG
Intuitive Surgical Inc
|
551.25 | 193.74B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
187.04 | 53.26B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
259.21 | 37.87B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
76.10 | 37.61B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
287.22 | 21.40B | 2.96B | 487.70M | 344.00M | 6.6758 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-23 | Herabstufung | Erste Group | Buy → Hold |
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Intuitive Surgical Completes Study on Robotic Bronchoscopy System for Lung Cancer Diagnosis - TipRanks
3 Healthcare Stocks to Buy Hand Over Fist in October - AOL.com
Intuitive Surgical, Inc. (ISRG): Investor Outlook With An 8.74% Upside Potential - DirectorsTalk Interviews
Intuitive Surgical vs. Medtronic: Which Stock Is the Better Buy? - MSN
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Leading vs lagging indicators on Intuitive Surgical Inc. performance2025 Fundamental Recap & Smart Allocation Stock Tips - newser.com
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock - Yahoo Finance
Argus Research Adjusts Intuitive Surgical Price Target to $630 From $600 - MarketScreener
Is Intuitive Surgical Inc. stock a top momentum playMarket Trend Summary & Fast Momentum Stock Entry Tips - newser.com
William O'Neil Initiates Intuitive Surgical at Buy - MarketScreener
Is Intuitive Surgical Inc. forming a bottoming base2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
Can Intuitive Surgical Inc. (Common Stock) (IUI) stock survive global slowdownBear Alert & Real-Time Volume Surge Alerts - newser.com
How Intuitive Surgical Inc. stock compares to growth peers2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
Is Intuitive Surgical Inc. stock entering bullish territoryJuly 2025 Intraday Action & Accurate Trade Setup Notifications - newser.com
Will Intuitive Surgical Inc. stock benefit from automationMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com
Intuitive Surgical (ISRG) Rises 23% Amid Healthcare Sector Gains - GuruFocus
2 Brilliant Medical Device Stocks to Buy Now and Hold for the Long Term - Yahoo Finance
Published on: 2025-10-26 02:42:41 - newser.com
Can Intuitive Surgical Inc. (IUI1) stock test all time highsJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - newser.com
Intuitive Surgical (ISRG): Exploring Valuation After Recent Share Price Surge - Sahm
Intuitive Surgical’s Stock Soars Amid Strong Performance - TipRanks
Published on: 2025-10-25 05:31:47 - newser.com
Intuitive Surgical Stock Forecast: Where Analysts See the Stock Going by 2027 - TIKR.com
Jim Cramer Highlights Intuitive Surgical Rally on Unexpected Procedure Growth - MSN
“I Like That,” Says Jim Cramer About Intuitive Surgical (ISRG) - Insider Monkey
Why Intuitive Surgical Stock Zoomed 23% Higher This Week - Yahoo Finance
Zacks Investment Ideas feature highlights: Intuitive Surgical's - The Globe and Mail
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):